Craft

Pierrel

Revenue

€23.1 M

FY, 2022

Pierrel Summary

Company Summary

Overview
Pierrel provides contract manufacturing services to the life science, biopharma, and pharmaceutical industries. It is involved in the development of various types of drugs, such as tube vials, bottles, ampoules, drops, sprays, syrups, gels, creams, ointments, and tablets; and production of active ingredients, including active substances and pharmaceutical formulations, as well as develops and manufactures dental anesthetics under the Orabloc brand name. The company also engages in the development, registration, and licensing of new drugs and medical devices.
Type
Private
Status
Active
Founded
1948
HQ
Capua, IT | view all locations
Website
https://www.pierrelgroup.com/en/
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Capua, Campania HQ

    Italy

    Appia 7 bis 46/48

Pierrel Financials

Summary Financials

Revenue (H1, 2023)
€13.4M
Gross profit (H1, 2023)
€10.2M
Net income (H1, 2023)
€1.3M
Cash (H1, 2023)
€4.8M
EBIT (H1, 2023)
€1.6M

Footer menu